Navigation Links
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Date:8/22/2007

- Revised Trial Examines Single, Higher, More Concentrated Dose of

Alfimeprase -

SAN CARLOS, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO) today announced enrollment of the first patient in the SONOMA-3 (Speedy Opening of Non-functional and Occluded catheters with Mini-dose Alfimeprase-3) trial evaluating lead product candidate, alfimeprase, for the treatment of central venous catheter occlusion (CO).

This open-label, single-arm trial will evaluate the safety and efficacy of a single 10 milligram dose of alfimeprase with a concentration of 5 milligrams per milliliter in up to 100 patients with occluded central venous catheters.

Data from a previous Phase 3 trial in the CO program, SONOMA-2, showed that alfimeprase restored catheter function in patients with occluded catheters within 15 minutes with a p-value of 0.022. It did not however, meet the more stringent p-value required for a single pivotal trial, less than 0.00125.

"Analysis of data from our previous Phase 3 SONOMA study provided further evidence that alfimeprase is an active thrombolytic which has the potential to dissolve clots quickly and rapidly restore catheter function, however, the dose and concentration we used did not generate results in line with the target product profile we believe necessary for commercial success in this market," said Michael Levy, M.D., executive vice president of research and development for Nuvelo. "Preclinical experiments have provided evidence that increasing the concentration can result in marked improvement in thrombolytic activity. Accordingly, we are resuming development of alfimeprase in CO to evaluate the potential of a single, higher, m
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
3. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
4. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
5. Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
6. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... New Jersey , 22. Mai 2013 ... für Fähigkeitsentwicklung und Beratung, gab heute bekannt, ... Chris Geraghty , zum Hauptgeschäftsführer ... 20 Jahre im Industriebereich wo er zahlreiche ... Nachfolge von Ray Baxter an, der als ...
(Date:5/22/2013)... Z-Medica, a leading developer and marketer of ... line of products designed to meet the unique needs ... EMS 4x4 Dressing, QuikClot ® EMS TraumaPad ... all custom-designed to help responders stop bleeding fast and ... a hospital or trauma center. The line includes products ...
(Date:5/22/2013)... May 22, 2013  MGT Capital Investments, Inc. (NYSE ... at the Second Annual Marcum LLP MicroCap Conference on ... City at the Grand Hyatt Hotel.  ... Officer, will update investors and answer questions. ... presentation is scheduled to begin at 9:30 a.m. EDT.  ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4
(Date:5/22/2013)... release is available in German . ... German Research Foundation) is establishing 11 new Research Training ... This decision was made by the relevant Grants Committee ... been awarded to the new programmes for an initial ... to the 11 new Research Training Groups, the Grants ...
(Date:5/22/2013)... run, encouraging a baby to finish the last ounce in ... Though the calories soon burn off, a bad habit remains. ... Forste found that clinical obesity at 24 months of age ... overweight at age two, it puts you on a trajectory ... and adolescence and as an adult," said Forste. "That,s a ...
(Date:5/22/2013)... The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to ... to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according ... Vaccine . , The U.S. Food and Drug Administration ... series of trials. These trials found that PCV13, which ... the previously used PCV7, did not increase the risk ...
(Date:5/22/2013)... TheBeautyPlace.com features Toppik and Bosley hair fibers, two hair ... thinning or balding hair. Hair loss treatments can be a ... loss during this waiting period, one can use these hair ... to hair transplant surgery in general. , Bosley and ... effective way to eliminate the appearance of balding and thinning ...
(Date:5/22/2013)... Houston, Texas (PRWEB) May 22, 2013 ... Genius On” in the Conrad Foundation’s Spirit of ... business and technical plan competition, free and open to ... , The Spirit of Innovation Challenge celebrates the ... man to walk on the Moon. The program challenges ...
Breaking Medicine News(10 mins):Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2Health News:TheBeautyPlace.com Divulges Two Innovative Hair Loss Concealers on the Market Today: Bosley Hair Thickening Fibers and Toppik Hair Building Fibers 2Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2
... ENT and ... joined the Practice — otolaryngologist Tamekia Wakefield, M.D. , ... Tarrytown, NY (Vocus) May 17, 2010 -- ENT ... physician has joined the Practice — otolaryngologist Tamekia Wakefield, M.D. She will join ENTA on ...
... A study published last week in Archives of Internal ... significantly lowered total and LDL-cholesterol levels, in addition to triglycerides. ... seven counties, is the most comprehensive study of its kind ... the risk of cardiovascular disease. The report, authored by ...
... ... look for. Flexible Assembly Systems uncovers the great torque screwdriver mystery with its very own ... ... don’t know what to look for. A torque screwdriver comes in many different variations, ...
... ... Business Process Consulting practice to guide emerging companies in their migration from manual, spreadsheet-based HR ... ... businesses stood to gain so much, by transitioning to automated HR platforms. A number ...
... ... on Thursday May 27, 2010 at the MacLaren Art Centre in Barrie, Ontario. The session ... , ... 17, 2010 -- Barrie area physicians are invited to attend the session which will start ...
... Software now ... ... Works, the developer of Statistical Process Control (SPC) and data collection software, announces the release ... process automation. The software offers many new enhancements for statistical process control, and ease of ...
Cached Medicine News:Health News:ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens , , 2Health News:ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens , , 3Health News:Pistachios: A handful a day may keep the cardiologist away 2Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2Health News:Economic Recovery and New Healthcare Legislation: The Stars Are Aligned for Increased Adoption of HR Management Systems (HRMS) 2Health News:Economic Recovery and New Healthcare Legislation: The Stars Are Aligned for Increased Adoption of HR Management Systems (HRMS) 3Health News:SPC Works Releases SPC Software for Process Automation 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: